ArticleAnnals of translational medicine2021

Combined everolimus and endocrine therapy in advanced HR-positive, HER2-negative Chinese breast cancer patients: a retrospective study.

Xia-Bo Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.